Gamma Investing LLC Nurix Therapeutics, Inc. Transaction History
Gamma Investing LLC
- $734 Billion
- Q2 2024
A detailed history of Gamma Investing LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 4,566 shares of NRIX stock, worth $98,945. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,566
Previous 1,142
299.82%
Holding current value
$98,945
Previous $16.8 Million
467.65%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NRIX
# of Institutions
183Shares Held
66.3MCall Options Held
40.9KPut Options Held
106K-
Black Rock Inc. New York, NY6.82MShares$148 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.42MShares$95.9 Million6.02% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.99MShares$86.5 Million2.73% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$84.1 Million1.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$78.6 Million0.0% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $1.02B
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...